Table 2.
Prescription rates for diuretics, RAAS-Is, beta-blockers alone or in combination*
| Medication | All | Sex | Below or above 75 y | SES | |||
| Male | Female | <75 y | >=75 y | low | high | ||
| N = 2771 | 1248 | 1523 | 873 | 1898 | 1235 | 253 | |
| Triple treatment (%) | |||||||
| • Diuretic and RAAS-I and beta-blocker | 18.0 | 18.4 | 17.7 | 23.7 | 15.4 | 16.7 | 22.1 |
| Two Drugs (%) | |||||||
| • Diuretic and RAAS-I | 28.2 | 29.0 | 27.6 | 21.7 | 31.2 | 30.5 | 26.1 |
| • Diuretic and beta-blocker | 10.6 | 9.8 | 11.2 | 11.1 | 10.3 | 10.5 | 10.7 |
| • RAAS-I and beta-blocker | 1.3 | 1.1 | 1.4 | 1.9 | 1.0 | 1.3 | 2.4 |
| Monotherapy (%) | |||||||
| • Diuretic monotherapy | 29.6 | 28.0 | 30.9 | 24.7 | 31.2 | 29.1 | 25.3 |
| • RAAS-I monotherapy | 3.0 | 3.5 | 2.5 | 4.6 | 2.2 | 2.8 | 3.6 |
| • beta-blocker monotherapy | 1.7 | 2.1 | 1.7 | 2.3 | 1.4 | 1.7 | 3.1 |
| Prescription of every drug separately (%) | |||||||
| • Diuretics | 86 | 85 | 88 | 83 | 88 | 87 | 83 |
| • RAAS-Is | 50 | 51 | 48 | 51 | 49 | 50 | 53 |
| • Betablockers | 32 | 32 | 32 | 40 | 29 | 31 | 39 |
| • Spironolactone | 20 | 20 | 20 | 20 | 20 | 21 | 21 |
| • digoxin | 25 | 23 | 26 | 19 | 27 | 25 | 23 |
* bold figures represent statistically significant differences on the chi-square test with p < 0.05